Subsequent research identified a GLTSCR1 polymorphism corresponding to a 3.5-fold increased risk of developing meningioma [98], further implicating GLTSCR1 with cancer types displaying rapid fatality [99, 100]. The gene discussed is BICRA; the disease is meningioma.